Reverb Therapeutics
Surjit Dixit is an accomplished scientist and entrepreneur with extensive experience in the biotechnology sector. Currently serving as Founder and Chief Scientific Officer at Reverb Therapeutics since December 2022, Dixit is focused on developing the proprietary Amplifier antibodies platform to enhance targeted immunotherapy. As Founding Director of id8 Biologics Consulting Inc. since March 2022, Dixit provides expert consulting in biological innovations. Previously, Dixit held the position of Vice President of Technology at Zymeworks, where the emphasis was on novel therapeutic protein design technologies. Dixit also worked at Wesleyan University as a Research Coordinator in Computational Biophysics, specializing in simulations of nucleic acids and protein complexes. Dixit holds a PhD in Chemistry from the Indian Institute of Technology, Delhi, and has completed post-doctoral research at Université Henri Poincaré, Nancy 1.
This person is not in any teams
This person is not in any offices
Reverb Therapeutics
We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant cytokines. We avoid issues such as systemic toxicity, immunogenicity and manufacturing concerns.